Eur Heart J. 1994 Jan;15(1):120-4. Treatment of recurrent pericarditis with colchicine. Millaire A(1), de Groote P, Decoulx E, Goullard L, Ducloux G.
The COlchicine for REcurrent pericarditis (CORE) trial, which enrolled 120 patients with recurrent pericarditis to evaluate colchicine therapy. Abstract. Background—The most troublesome complication of acute pericarditis is recurrent episodes of pericardial inflammation, occurring in 15% to 32% of. Colchicine — The majority of patients have prompt resolution of symptoms without recurrent pericarditis when treated with NSAIDS alone.
Thus, Imazio et al reported on the results of the colchicine for recurrent pericarditis 2 (CORP-2) trial. CORP-2 was a randomized, controlled trial. BackgroundColchicine seems to be a good drug for treating recurrences of pericarditis after conventional treatment failure, but no clinical trial.
Colchicine has been shown to be promising for the secondary prevention of recurrent pericarditis in the CORE (recurrent pericarditis), COPE. Colchicine is effective for the treatment of recurrent pericarditis. However, conclusive data are lacking regarding the use of colchicine during a. Effect of Anakinra on Recurrent Pericarditis Among Patients With Colchicine Resistance and Corticosteroid Dependence: The AIRTRIP.